NASDAQ · Analyst Forecast

Amgen Inc. (AMGN) Stock Forecast & Price Target

$464.15 NASDAQ: AMGN Market Cap $251.06B

Price as of Nov 16, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Amgen Inc. (AMGN), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Amgen Inc., analysts forecast revenue rising from $36.36B in 2025 to $47.11B in 2030; the average estimate for 2030 earnings per share is $30.98; with published estimates ranging from $29.70 to $32.90; 27 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$464.15
Consensus targetThe average of the price targets analysts have published.$418.47
Median targetThe middle target, less affected by a single outlier.$415.00
Highest targetThe most optimistic published target.$515.00
Lowest targetThe most pessimistic published target.$230.00
Difference from priceHow far the consensus target sits from today’s price.-9.8%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$36.16B$36.36B$36.77B23
2026$38.91B$39.43B$39.94B22
2027$39.86B$41.25B$42.45B23
2028$40.24B$43.21B$48.18B27
2029$43.48B$44.90B$47.05B13
2030$45.62B$47.11B$49.36B13

Earnings per share forecast

YearLowAverageHighAnalysts
2025$21.07$21.32$22.1123
2026$23.17$23.50$24.1322
2027$23.50$24.99$26.5423
2028$20.93$26.84$39.3327
2029$27.51$28.69$30.4713
2030$29.70$30.98$32.9013

Amgen Inc. (AMGN) forecast — frequently asked questions

What is the analyst price target for Amgen Inc.?

Analysts covering Amgen Inc. (AMGN) have a consensus price target of $418.47, 9.8% below the current price of $464.15. Published targets range from $230.00 to $515.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Amgen Inc.'s earnings?

The average analyst estimate for Amgen Inc. (AMGN) earnings per share in 2030 is 30.98, with individual estimates between 29.70 and 32.90.

How much revenue is Amgen Inc. expected to make?

Analysts forecast Amgen Inc. (AMGN) revenue of $47.11B in 2030, based on 13 published estimates.

How many analysts cover AMGN?

27 analysts contribute estimates for Amgen Inc. (AMGN). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - General stocks

LLY forecastJNJ forecastABBV forecastMRK forecastNVS forecastAZN forecastGILD forecastNVO forecastPFE forecastBMY forecastAll Drug Manufacturers - General stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.